MycoBiomDB – Record Details (MyCo_2942)

Biomarker Record Details

Database ID: MyCo_2942
DB IDMyCo_2942
TitleA prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples
Year2010
PMID20825441
Fungal Diseases involvedInvasive pulmonary aspergillosis
Associated Medical ConditionNone
GenusAspergillus
Speciesspp.
OrganismAspergillus spp.
Ethical StatementThe study was approved by the Ethics Committee, Hospital Universitario 12 de Octubre, Madrid, Spain
Site of InfectionNone
Opportunistic invasiveInvasive
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameGM
Biomarker Full NameGalactomannan
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationSpain
CohortOver a period of 21 months 847 patients were admitted to the ICU; 191 (22.5%) had pneumonia. Of these, 93 (48.6%) had host factors for IFD and 51 (26.7%) met the criteria for inclusion (13 case patients in the IFD group and 38 patients in the control group without evidence of IFD)
Cohort No.51
Age Group57.5±15.1
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismNone
TechniqueELISA
Analysis MethodFDA Approved -Platelia Aspergillus Ag ELISA
ELISA kitsELISA Kit- Platelia Aspergillus (Platelia Aspergillus EIA; Bio-Rad, Marnes la Coquette, France)
Assay DataFDA- Fungitell®, Cape Cod International, Inc.; Falmounth, MA, USA
Validation Techniques usedFDA Approved-Fungitell assay, FDA Approved -Platelia Aspergillus Ag ELISA
Up Regulation Down RegulationIncrease
Sequence DataNone
External LinkNone